Literature DB >> 6210825

C3b inactivator and beta 1H.

L G Crossley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6210825

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

Authors:  C F Catterall; A Lyons; R B Sim; A J Day; T J Harris
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

2.  Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18.

Authors:  N Dana; D M Fathallah; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering.

Authors:  S J Perkins; K F Smith; R B Sim
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

4.  Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).

Authors:  M A Arnaout; R F Todd; N Dana; J Melamed; S F Schlossman; H R Colten
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

Authors:  Y C Ng; D K Peters; S A Cederholm-Williams; M J Walport
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

6.  Deficiency of a surface membrane glycoprotein (Mo1) in man.

Authors:  N Dana; R F Todd; J Pitt; T A Springer; M A Arnaout
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.